I agree that this site is using cookies. You can find further informations here.
X
Cloughesy, Timothy
921  results:
Search for persons X
?
1

ACTION: a randomized phase 3 study of ONC201 (dordaviprone)..:

Arrillaga-Romany, Isabel ; Lassman, Andrew ; McGovern, Susan L...
Neuro-Oncology.  26 (2024)  Supplement_2 - p. S173-S181 , 2024
Link: https://doi.org/10.1093/..
 
?
2

DIPG-55. DIRECT BRAIN-TO-BRAIN WORKFLOW ENABLES THE PRECLIN..:

Tum, Hong ; Tse, Christopher ; Salinas, Jennifer...
Neuro-Oncology.  25 (2023)  Supplement_1 - p. i26-i26 , 2023
Link: https://doi.org/10.1093/..
 
?
3

CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB ..:

Nassiri, Farshad ; Patil, Vikas ; Yefet, Leeor...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v65-v66 , 2023
Link: https://doi.org/10.1093/..
 
?
4

NIMG-62. QUANTITATIVE ASSESSMENT OF T2-FLAIR MISMATCH IN HU..:

Cho, Nicholas ; Sanvito, Francesco ; Le, Vien...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v200-v200 , 2023
Link: https://doi.org/10.1093/..
 
?
5

LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR ..:

Wen, Patrick ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v310-v311 , 2023
Link: https://doi.org/10.1093/..
 
?
6

DNAR-05. EXCEPTIONAL RESPONDERS TO BASE EXCISION REPAIR (BE..:

Ozair, Ahmad ; Drappatz, Jan ; Ye, Xiaobu...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v99-v99 , 2023
Link: https://doi.org/10.1093/..
 
?
7

NIMG-50. TOTAL TUMOR CELLULARITY AND CELLULAR GROWTH RATES ..:

Oshima, Sonoko ; Yao, Jingwen ; Bobholz, Samuel...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v197-v197 , 2023
Link: https://doi.org/10.1093/..
 
?
8

CTIM-14. PHASE 1 SAFETY LEAD-IN AND RANDOMIZED OPEN-LABEL P..:

Wen, Patrick ; Peters, Katherine ; de la Fuente, Macarena...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v64-v64 , 2023
Link: https://doi.org/10.1093/..
 
?
9

CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASID..:

Cloughesy, Timothy ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v86-v87 , 2023
Link: https://doi.org/10.1093/..
 
?
10

CLRM-07 RANO 2.0: PROPOSAL FOR AN UPDATE TO THE RESPONSE AS..:

Wen, Patrick ; Van Den Bent, Martin ; Youssef, Gilbert...
Neuro-Oncology Advances.  5 (2023)  Supplement_3 - p. iii8-iii8 , 2023
Link: https://doi.org/10.1093/..
 
?
11

TMET-12. CDKN2A DELETION REMODELS LIPID METABOLISM TO PRIME..:

Minami, Jenna ; Morrow, Danielle ; Bayley, Nicholas...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v275-v275 , 2023
Link: https://doi.org/10.1093/..
 
?
12

IMMU-05. CD8 IMMUNOPET IMAGING IS ABLE TO MONITOR THE IMMUN..:

Prins, Robert ; Konik, Arda ; Sun, Lu...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v142-v142 , 2023
Link: https://doi.org/10.1093/..
 
?
13

IMMU-03. UTILIZING IN SILICO SINGLE-CELL TRANSCRIPTOMIC AND..:

Lee, Alexander ; Sun, Lu ; Chow, Frances...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v141-v141 , 2023
Link: https://doi.org/10.1093/..
 
?
14

QOL-17. SLEEP QUALITY DIMENSIONS IN LOW AND HIGH-GRADE GLIO..:

Chen, Erica ; Wang, Chencai ; Wall, Lucy...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v252-v252 , 2023
Link: https://doi.org/10.1093/..
 
?
15

CSIG-04. INTEGRATED MOLECULAR AND FUNCTIONAL CHARACTERIZATI..:

Fernandez, Elizabeth ; Mai, Wilson ; Song, Kai...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v40-v40 , 2023
Link: https://doi.org/10.1093/..
 
1-15